EP1504099A4 - NEW NUCLEIC ACIDS AND POLYPEPTIDES - Google Patents

NEW NUCLEIC ACIDS AND POLYPEPTIDES

Info

Publication number
EP1504099A4
EP1504099A4 EP02805571A EP02805571A EP1504099A4 EP 1504099 A4 EP1504099 A4 EP 1504099A4 EP 02805571 A EP02805571 A EP 02805571A EP 02805571 A EP02805571 A EP 02805571A EP 1504099 A4 EP1504099 A4 EP 1504099A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02805571A
Other languages
German (de)
French (fr)
Other versions
EP1504099A2 (en
Inventor
Y Tom Tang
Vinod Asundi
Ryle W Goodrich
Feiyan Ren
Jie Zhang
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Tom Wehrman
Gezhi Weng
Ping Zhou
Radoje T Drmanac
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Chongjun Xu
Bryan J Boyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/128,558 external-priority patent/US20040219521A1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1504099A2 publication Critical patent/EP1504099A2/en
Publication of EP1504099A4 publication Critical patent/EP1504099A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP02805571A 2001-12-10 2002-12-10 NEW NUCLEIC ACIDS AND POLYPEPTIDES Withdrawn EP1504099A4 (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US128558 1987-12-03
US33973901P 2001-12-10 2001-12-10
US339739P 2001-12-10
US33945301P 2001-12-11 2001-12-11
US339453P 2001-12-11
US36538402P 2002-03-14 2002-03-14
US36509102P 2002-03-14 2002-03-14
US365384P 2002-03-14
US365091P 2002-03-14
US37238102P 2002-04-12 2002-04-12
US37261502P 2002-04-12 2002-04-12
US372615P 2002-04-12
US372381P 2002-04-12
US10/128,558 US20040219521A1 (en) 2000-01-21 2002-04-22 Novel nucleic acids and polypeptides
US37604502P 2002-04-24 2002-04-24
US376045P 2002-04-24
PCT/US2002/039555 WO2003054152A2 (en) 2001-12-10 2002-12-10 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1504099A2 EP1504099A2 (en) 2005-02-09
EP1504099A4 true EP1504099A4 (en) 2006-05-10

Family

ID=27574889

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02805571A Withdrawn EP1504099A4 (en) 2001-12-10 2002-12-10 NEW NUCLEIC ACIDS AND POLYPEPTIDES

Country Status (4)

Country Link
EP (1) EP1504099A4 (en)
AU (1) AU2002366951A1 (en)
CA (1) CA2469941A1 (en)
WO (1) WO2003054152A2 (en)

Families Citing this family (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9315698U1 (en) * 1993-10-14 1993-12-23 BÜCHI LABORATORIUMS-TECHNIK AG, Flawil Evaporator flask for a rotary evaporator
EP1434783A4 (en) * 2001-03-16 2006-06-07 Lilly Co Eli Lp mammalian proteins; related reagents
CA2633171C (en) 2001-06-20 2012-11-20 Genentech, Inc. Antibodies against tumor-associated antigenic target (tat) polypeptides
US20030068691A1 (en) * 2001-07-16 2003-04-10 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
CA2458818A1 (en) * 2001-08-30 2003-04-10 Nuvelo, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
CA2462790A1 (en) * 2001-10-04 2003-04-10 Immunex Corporation Ul16 binding protein 4
EP1562969A4 (en) 2002-03-28 2006-07-05 Bristol Myers Squibb Co Novel human cell surface protein with immunoglobulin folds, bgs-19
JPWO2003091436A1 (en) 2002-04-26 2005-09-02 藤沢薬品工業株式会社 New 35 kd protein
AU2003239777A1 (en) * 2002-07-05 2004-01-23 Borean Pharma A/S Multimerised growth hormone fusion proteins
US20040121370A1 (en) 2002-09-11 2004-06-24 Genentech, Inc. Novel composition and methods for the treatment of immune related diseases
ES2320443T3 (en) 2002-09-30 2009-05-22 Oncotherapy Science, Inc. GENES AND POLYPEPTIDES RELATED TO HUMAN PANCREATIC CANCERS.
WO2004085648A2 (en) 2003-03-19 2004-10-07 Biogen Idec Ma Inc. Nogo receptor binding protein
CA2540701A1 (en) 2003-09-29 2005-04-07 Chugai Seiyaku Kabushiki Kaisha Proteins expressed in nk cells
EP1679372B1 (en) * 2003-10-30 2009-02-18 Kazusa DNA Research Institute Foundation Novel plexin polypeptide, dna encoding the same and use thereof
US7498298B2 (en) 2003-11-06 2009-03-03 Seattle Genetics, Inc. Monomethylvaline compounds capable of conjugation to ligands
EP1727560B1 (en) * 2004-01-27 2012-09-12 Kyowa Hakko Kirin Co., Ltd. Gastrointestinal proliferative factor and uses thereof
GB0403491D0 (en) * 2004-02-17 2004-03-24 Univ Cambridge Tech Polypeptides, methods and means
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7901881B2 (en) 2004-04-09 2011-03-08 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic tool for diagnosing benign versus malignant thyroid lesions
KR20120064120A (en) 2004-06-01 2012-06-18 제넨테크, 인크. Antibody drug conjugates and methods
PT1776136E (en) 2004-06-24 2012-12-05 Biogen Idec Inc Treatment of conditions involving demyelination
EP1771578A2 (en) * 2004-07-23 2007-04-11 EVOTEC Neurosciences GmbH Diagnostic and therapeutic use of slim3 for neurodegenerative diseases
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
KR101270829B1 (en) 2004-09-23 2013-06-07 제넨테크, 인크. Cystein engineered antibodies and conjugates
EP3214095B1 (en) 2005-05-12 2019-12-11 ZymoGenetics, Inc. Compositions and methods for modulating immune responses
SI1904104T1 (en) 2005-07-08 2013-12-31 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
AU2006291990B2 (en) 2005-09-13 2012-05-31 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
GB0522113D0 (en) * 2005-10-28 2005-12-07 Ares Trading Sa vWFA-domain containing proteins
GB0525999D0 (en) * 2005-12-21 2006-02-01 Ares Trading Sa Novel members of the kazal family of serine protease inhibitors
GB0615287D0 (en) * 2006-08-01 2006-09-06 Ares Trading Sa Integral membrane protein
US20090068107A1 (en) * 2006-10-02 2009-03-12 The Scripps Research Institute Enzyme regulating ether lipid signaling pathways
GB0620735D0 (en) * 2006-10-18 2006-11-29 Ares Trading Sa Proteins
DK2173379T3 (en) 2007-07-02 2015-12-07 Oncomed Pharm Inc Compositions and methods for treatment and diagnosis of cancer
GB0805159D0 (en) * 2008-03-19 2008-04-23 Sancho Madrid David Immune modulation via C-type lectin
WO2009026660A1 (en) 2007-08-30 2009-03-05 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
KR101662622B1 (en) 2007-10-04 2016-10-05 지모제넥틱스, 인코포레이티드 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
CA2702630C (en) * 2007-11-08 2017-11-21 Biogen Idec Ma Inc. Use of lingo-4 antagonists in the treatment of conditions involving demyelination
EP3208612B1 (en) 2008-04-09 2019-09-18 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20110110861A1 (en) * 2008-05-13 2011-05-12 Mireille Hanna Lahoud Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
DK2982695T3 (en) 2008-07-09 2019-05-13 Biogen Ma Inc COMPOSITIONS CONCERNING ANTIBODIES AGAINST LINGO OR FRAGMENTS THEREOF
US8227417B2 (en) 2008-07-25 2012-07-24 The United States Of America As Represented By The Secretary, Department Of Health And Human Services HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
ES2579909T3 (en) 2009-02-03 2016-08-17 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial and organoid stem cells comprising said stem cells
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
JP2012531212A (en) 2009-07-03 2012-12-10 アビペップ ピーティーワイ リミテッド Immunoconjugate and method for producing the same
WO2011004404A1 (en) * 2009-07-10 2011-01-13 Decode Genetics Ehf Genetic variants for predicting risk of glaucoma
CA2809819A1 (en) 2009-09-09 2011-03-17 Centrose, Llc Extracellular targeted drug conjugates
CN102666585B (en) 2009-11-24 2015-02-18 阿莱斯亚生物疗法股份有限公司 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
SG181814A1 (en) 2009-12-23 2012-07-30 Avipep Pty Ltd Immuno-conjugates and methods for producing them 2
DK2528625T3 (en) 2010-04-15 2013-10-14 Spirogen Sarl Pyrrolobenzodiazepines and their conjugates
BR112012030311A2 (en) 2010-06-08 2017-01-24 Genentech Inc antibody
BR112013005872A2 (en) 2010-09-22 2019-09-24 Alios Biopharma Inc compounds, pharmaceutical composition and their uses
JP5889912B2 (en) 2010-11-17 2016-03-22 ジェネンテック， インコーポレイテッド Alaninyl maytansinol antibody conjugate
EP2699597B1 (en) 2011-04-21 2016-06-01 Garvan Institute of Medical Research Modified variable domain molecules and methods for producing and using them b
KR101992502B1 (en) 2011-05-12 2019-06-24 제넨테크, 인크. Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides
BR112014000765A2 (en) 2011-07-15 2017-06-13 Oncomed Pharm Inc rspo binding agents and their uses
JP6104257B2 (en) 2011-10-14 2017-03-29 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ Pyrrolobenzodiazepine and its conjugates
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc Substituted phosphorothioate nucleotide analogs
WO2013123588A1 (en) 2012-02-22 2013-08-29 Alethia Biotherapeutics Inc. Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
CN104470541A (en) 2012-05-14 2015-03-25 比奥根艾迪克Ma公司 Lingo-2 antagonists for treatment of conditions involving motor neurons
IN2015KN00350A (en) 2012-07-13 2015-07-10 Oncomed Pharm Inc
DK2906298T3 (en) 2012-10-12 2018-12-17 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
AU2013328625B2 (en) 2012-10-12 2016-12-15 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
US10751346B2 (en) 2012-10-12 2020-08-25 Medimmune Limited Pyrrolobenzodiazepine—anti-PSMA antibody conjugates
US10695433B2 (en) 2012-10-12 2020-06-30 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
ES2649990T3 (en) 2012-10-12 2018-01-16 Medimmune Limited Anti-CD22-pyrrolobenzodiazepine antibody conjugates
CN104837502B (en) 2012-10-12 2018-08-10 麦迪穆有限责任公司 Pyrrolobenzodiazepines and their conjugates
EP2906250B1 (en) 2012-10-12 2018-05-30 ADC Therapeutics SA Pyrrolobenzodiazepine-anti-psma antibody conjugates
CN105189507A (en) 2012-12-21 2015-12-23 斯皮罗根有限公司 Pyrrolobenzodiazepines and conjugates thereof
CN105246894A (en) 2012-12-21 2016-01-13 斯皮罗根有限公司 Asymmetric pyrrolobenzodiazepine dimers for the treatment of proliferative and autoimmune diseases
CA2905181C (en) 2013-03-13 2020-06-02 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
NZ710746A (en) 2013-03-13 2018-11-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
SG11201507214SA (en) 2013-03-13 2015-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CA2916681A1 (en) 2013-07-16 2015-01-22 Genentech, Inc. Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
EP3033111B1 (en) 2013-08-12 2019-03-13 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
EP3054985B1 (en) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
EP3054986B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
JP6671292B2 (en) 2013-12-16 2020-03-25 ジェネンテック， インコーポレイテッド Peptidomimetic compounds and antibody-drug conjugates thereof
KR20170042495A (en) 2013-12-16 2017-04-19 제넨테크, 인크. Peptidomimetic compounds and antibody-drug conjugates thereof
BR112016013258A2 (en) 2013-12-16 2018-01-16 Genentech Inc antibody-drug conjugate, pharmaceutical composition, method for treating cancer and kit
JP6531166B2 (en) 2014-09-10 2019-06-12 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ Pyrrolobenzodiazepine and its conjugate
MX2017003123A (en) 2014-09-12 2017-05-12 Genentech Inc Cysteine engineered antibodies and conjugates.
WO2016040825A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP2017528523A (en) 2014-09-16 2017-09-28 オンコメッド ファーマシューティカルズ インコーポレイテッド Treatment of fibrotic diseases
US20160074527A1 (en) 2014-09-17 2016-03-17 Genentech, Inc. Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
AU2015352545B2 (en) 2014-11-25 2020-10-15 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
MX2017007169A (en) 2014-12-03 2018-05-02 Genentech Inc Quaternary amine compounds and antibody-drug conjugates thereof.
JP2018504400A (en) 2015-01-08 2018-02-15 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． LINGO-1 antagonist and use for treatment of demyelinating disorders
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
CA2994858C (en) 2015-09-25 2024-01-23 Genentech, Inc. Anti-tigit antibodies and methods of use
CA2996902C (en) 2015-10-02 2020-06-02 Genentech, Inc. Pyrrolobenzodiazepine antibody drug conjugates and methods of use
PH12022551111A1 (en) 2015-10-05 2023-08-23 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
EP3362100B1 (en) 2015-10-16 2022-06-22 Genentech, Inc. Hindered disulfide drug conjugates
EP3365025B1 (en) 2015-10-20 2020-07-15 Genentech, Inc. Calicheamicin-antibody-drug conjugates and methods of use
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
US20170315132A1 (en) 2016-03-25 2017-11-02 Genentech, Inc. Multiplexed total antibody and antibody-conjugated drug quantification assay
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
EP3458101B1 (en) 2016-05-20 2020-12-30 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
EP3465221B1 (en) 2016-05-27 2020-07-22 H. Hoffnabb-La Roche Ag Bioanalytical method for the characterization of site-specific antibody-drug conjugates
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
WO2018031662A1 (en) 2016-08-11 2018-02-15 Genentech, Inc. Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
EP3522933B1 (en) 2016-10-05 2021-12-15 F. Hoffmann-La Roche AG Methods for preparing antibody drug conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
WO2018115879A1 (en) 2016-12-21 2018-06-28 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
MX375569B (en) 2017-02-08 2025-03-04 Adc Therapeutics Sa PYRROLOBENZODIAZEPINES AND ANTIBODIES CONJUGATES
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
PT3612537T (en) 2017-04-18 2022-08-29 Medimmune Ltd Pyrrolobenzodiazepine conjugates
ES2977788T3 (en) 2017-04-20 2024-08-30 Adc Therapeutics Sa Combination therapy with an anti-AXL antibody-drug conjugate
MX2019015042A (en) 2017-06-14 2020-08-06 Adc Therapeutics Sa DOSAGE REGIME.
DK3668874T3 (en) 2017-08-18 2022-02-14 Medimmune Ltd Pyrrolobenzodiazepine conjugates
IL273387B2 (en) 2017-09-20 2023-10-01 Ph Pharma Co Ltd Thailanstatin analogs
GB201721615D0 (en) 2017-12-21 2018-02-07 Koninklijke Nederlandse Akademie Van Wetenschappen Immune cell organoid co-cultures
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
WO2019178364A2 (en) * 2018-03-14 2019-09-19 Elstar Therapeutics, Inc. Multifunctional molecules and uses thereof
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP2021534196A (en) 2018-08-23 2021-12-09 シージェン インコーポレイテッド Anti-TIGIT antibody
GB201814281D0 (en) 2018-09-03 2018-10-17 Femtogenix Ltd Cytotoxic agents
JP7708662B2 (en) 2018-10-24 2025-07-15 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Conjugated chemical degraders and methods of use
EP3894427A1 (en) 2018-12-10 2021-10-20 Genentech, Inc. Photocrosslinking peptides for site specific conjugation to fc-containing proteins
GB201901197D0 (en) 2019-01-29 2019-03-20 Femtogenix Ltd G-A Crosslinking cytotoxic agents
KR102890251B1 (en) 2019-03-15 2025-11-25 메드임뮨 리미티드 Azetidobenzodiazepine dimers and conjugates comprising the same for use in the treatment of cancer
GB2597532A (en) 2020-07-28 2022-02-02 Femtogenix Ltd Cytotoxic compounds
BR112023021034A2 (en) * 2021-04-14 2023-12-12 Tscan Therapeutics Inc BINDING PROTEINS THAT RECOGNIZE HA-2 ANTIGEN AND USES THEREOF
CN117980327A (en) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 Specific conjugation of antibodies
GB202211117D0 (en) * 2022-07-29 2022-09-14 Replay Holdings Llc Compositions and methods for non-immunogenecity
EP4637833A2 (en) 2022-12-23 2025-10-29 Genentech, Inc. Cereblon degrader conjugates, and uses thereof
EP4698230A2 (en) 2023-04-17 2026-02-25 Peak Bio, Inc. Antibodies and antibody-drug conjugates and methods of use and synthetic processes and intermediates
WO2026006688A2 (en) 2024-06-28 2026-01-02 Firefly Bio, Inc. Degrader antibody conjugates and uses thereof
WO2026006689A2 (en) 2024-06-28 2026-01-02 Firefly Bio, Inc. Bcl-xl degrader antibody conjugates and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 22 December 1994 (1994-12-22), "Homo sapiens glutathione S-transferase theta 2 (GSTT2) mRNA, complete cds.", XP002357957, retrieved from EBI accession no. EM_PRO:HSGSTT2A Database accession no. L38503 *
DATABASE UniProt [online] 1 April 1993 (1993-04-01), "Glutathione S-transferase theta 2 (EC 2.5.1.18) (GST class-theta 2).", XP002357958, retrieved from EBI accession no. UNIPROT:GSTT2_HUMAN Database accession no. P30712 *

Also Published As

Publication number Publication date
AU2002366951A1 (en) 2003-07-09
WO2003054152A3 (en) 2004-12-16
EP1504099A2 (en) 2005-02-09
CA2469941A1 (en) 2003-07-03
WO2003054152A2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
EP1504099A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1432800A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1325120A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1341804A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1556490A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1242443A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1368475A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1276751A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EE200300107A (en) Novel receptor nucleic acids and polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1483386A4 (en) NEW NUCLEIC ACIDS AND SPECIFIC POLYPEPTIDES
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1470238A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1424392A4 (en) NEW SECRETION PROTEINS AND RELATED DNA
EP1341803A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1282635A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1268762A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1383533A4 (en) Proteins and nucleic acids encoding same
EP1359932A4 (en) TIP39 POLYPEPTIDE
EP1370675A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
ATE328003T1 (en) CHIMERIC NUCLEIC ACIDS AND POLYPEPTIDES FROM LYSSAVIRUS
AU7005801A (en) Gp354 nucleic acids and polypeptides
DE60217711D1 (en) PTP10D NUCLEIC ACIDS AND PEPTIDES IN THE REGULATION OF ENERGY HOMEOSTASIS
DE60044849D1 (en) SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS THEREFOR CODED
EP1409523A4 (en) Pancam nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040705

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/00 19950101ALI20051208BHEP

Ipc: C12N 15/00 19800101AFI20051208BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20060328

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20061002